SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-001519
Filing Date
2017-03-15
Accepted
2017-03-15 06:05:15
Documents
3
Period of Report
2017-03-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_031517.htm 8-K 15607
2 EXHIBIT 1.1 exh_11.htm EX-1.1 201223
3 EXHIBIT 5.1 exh_51.htm EX-5.1 6166
  Complete submission text file 0001171843-17-001519.txt   224123
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 17689760
SIC: 2836 Biological Products, (No Diagnostic Substances)